AIM2 and neoplasm: Subsequent research identified that AIM2 enhanced PD-L1 expression by modulating M2 macrophage polarization and the JAK/STAT3 signaling pathway, thereby inhibiting the immune infiltration of CD8+ T cells and preventing CD8+ T cell-induced apoptosis of tumor cells, ultimately facilitating immune evasion in LUAD (69).